Prostatis Group’s First Trust SMID Cap Rising Dividend Achievers ETF SDVY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.56M Sell
90,364
-4,329
-5% -$176K 0.91% 33
2025
Q4
$3.63M Buy
94,693
+1,050
+1% +$39.9K 0.87% 36
2025
Q3
$3.56M Buy
93,643
+23,337
+33% +$866K 0.89% 31
2025
Q2
$2.48M Sell
70,306
-25,894
-27% -$869K 0.71% 43
2025
Q1
$3.22M Sell
96,200
-14,018
-13% -$500K 1.02% 25
2024
Q4
$3.95M Buy
110,218
+16,480
+18% +$617K 1.15% 22
2024
Q3
$3.41M Buy
93,738
+7,003
+8% +$244K 1.12% 24
2024
Q2
$2.94M Buy
86,735
+10,967
+14% +$369K 1.03% 27
2024
Q1
$2.64M Buy
+75,768
New +$2.47M 1% 31
2022
Q4
Sell
-120,832
Closed -$2.79M 108
2022
Q3
$2.79M Buy
+120,832
New +$3.07M 3.22% 8

Other funds holding SDVY

Prostatis Group's SDVY Position: Q1 2026 in Review

Prostatis Group reduced its First Trust SMID Cap Rising Dividend Achievers ETF (SDVY) stake by 4.6% in Q1 2026, selling an estimated $176K and leaving 90,364 shares worth $3.56M. The position accounts for 0.91% of the portfolio, ranked #33.

Prostatis Group first reported a position in SDVY in Q3 2022 and has held it in 10 quarters since. The position peaked at $3.95M in Q4 2024. 564 funds tracked by Wall St. Rank hold SDVY as of Q1 2026.

  • Prostatis Group held 90,364 shares of First Trust SMID Cap Rising Dividend Achievers ETF worth $3.56M as of Q1 2026.
  • Prostatis Group sold 4,329 First Trust SMID Cap Rising Dividend Achievers ETF shares in Q1 2026, an estimated $176K.
  • First Trust SMID Cap Rising Dividend Achievers ETF made up 0.91% of Prostatis Group's portfolio in Q1 2026, its #33 holding.
  • Prostatis Group first reported a position in First Trust SMID Cap Rising Dividend Achievers ETF in Q3 2022 and has held it in 10 quarters since.
  • Prostatis Group's First Trust SMID Cap Rising Dividend Achievers ETF position peaked at $3.95M in Q4 2024.
  • 564 funds tracked by Wall St. Rank held First Trust SMID Cap Rising Dividend Achievers ETF as of Q1 2026.

Based on Prostatis Group's 13F filing for Q1 2026, filed 12 May 2026.